The guideline recommends that all inpatients need to monitor blood glucose and provides an ideal target for blood glucose control in inpatients who do not require intensive care, and introduces how to achieve blood glucose targets.
This Chinese-language document summarizes the 2012 American Endocrine Society clinical practice guideline for hyperglycemia care in non-critically ill hospitalized patients, published in Diabetes World, Vol 6, No 2, February 2012.
It recommends laboratory glucose testing for all patients at admission and sets a pre-meal target below 140 mg/dL and a random glucose target below 180 mg/dL for most patients. Treatment guidance covers insulin protocols, hypoglycemia management, perioperative care, and nutrition-related glucose control. This manual is written in Chinese.
Most non-critically ill patients should have pre-meal glucose below 140 mg/dL and random glucose below 180 mg/dL.
If glucose falls below 100 mg/dL, the treatment plan should be reassessed; below 70 mg/dL (3.9 mmol/L), it should be modified.
Yes. All patients should have laboratory blood glucose testing on admission, regardless of whether they were previously diagnosed with diabetes.